Multi-Therapy Infusion Pumps Market Outlook (2023 to 2033)

The global multi-therapy infusion pumps market size is projected to reach USD 370.4 million in 2023. Over the next ten years, global multi-therapy infusion pump sales are likely to soar at 6.6% CAGR. By 2033, total market valuation is anticipated to surpass USD 699.4 million.

Multi-therapy infusion pumps are innovative drug delivery devices used for various therapeutic purposes. They are mostly employed for administration of medications and fluids into a patient’s body in a controlled manner.

Multi-therapy infusion pumps can safely and effectively deliver fluids in small or large amounts. They are being used in hospitals, clinics, and home care settings to accurately deliver nutrients and medications such as antibiotics, hormones, chemotherapy drugs, etc.

The ability of multi-therapy infusion pumps to accurately deliver multiple infusion therapies is making them quite popular. These pumps can deliver optimized patient outcomes and reduce the chances of errors.

Multi-therapy infusion pumps are becoming ideal alternatives to manual fluid administration pumps. This is because they can deliver fluids at precise frequencies, intervals, and volumes. Growing awareness about the benefits of these pumps will play a key role in fueling their demand.

Multi-therapy infusion pumps help users to meet the demanding clinical needs of today’s patients by allowing accurate delivery of medication and fluids and medication in a controlled manner.

Increasing prevalence of chronic diseases is providing a strong impetus to the growth of the multi-therapy infusion pumps industry.

Multi-therapy infusion pumps are being increasingly used to provide medication and nutrition to patients suffering from chronic illnesses such as cancer, malnutrition, gastrointestinal disorders, etc. Hence, rise in cases of diseases will eventually bolster multi-therapy infusion pump sales.

Growing awareness regarding health procedures and surgery aftercare , and rising popularity of homecare medical devices is likely to further boost the market.

Rising adoption of multi-therapy infusion pumps in home care settings is throwing a new light into the global multi-therapy infusion pumps industry.

Today, people are spending large amounts on purchasing portable medical devices such as multi-therapy infusion pumps to reduce hospital expenses. This is expected to create a slew of opportunities for the multi-therapy infusion manufacturers during the forecast period.

The deployment of multi-therapy infusion pumps at home to decrease hospital spending is propelling market expansion. Further, the impact of technological improvements in healthcare and therapeutic services is being expanded and made more accessible.

Infusion pump technological advancements result in the prevention of drug errors and increase patient care and satisfaction. These advances lead to better clinical outcomes by using patient monitoring technology to inform and guide clinicians' treatment decisions.

The increased prevalence of diabetes worldwide, rising healthcare costs, and the introduction of innovative technologies for the creation of devices such as insulin patch pumps will positively impact the market.

Leading players are focusing on launching new and advanced solutions for varied clinical uses in hospital, homecare, and ambulatory settings. By combining high-end volumetric infusion pump functionality with compact size and low weight, companies are developing novel solutions that offer ease of use and reliability.

For instance, in April 2023, Avoset, a novel connected infusion multi-therapy ambulatory infusion system, was introduced by Eitan Medical. The new drug delivery solution is designed to enhance patient safety and improve user experience. Featuring a simplified & compact technology, Avoset can continuously monitor infusion treatment data remotely.

Development of these drug delivery solutions will help companies to increase their sales, expand their customer base, and solidify their position in the global market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Drivers Propelling Demand for Multi-Therapy Infusion Pumps

  • As the desire to shorten hospital stays grows, people are increasingly opting for multi-purpose infusion pumps that are less expensive and easier to operate than most other pumps.
  • Increasing need for self-controlled infusion pumps in diabetic patients for type 1 diabetes management, as well as in chemotherapy treatment in cancer patients will bolster sales.
  • The ability of multi-therapy infusion pump technology to reduce/prevent human operating errors such as improper dose, rate, and pump failure will fuel widespread adoption of these pumps.
  • Rising popularity of homecare services and infrastructure will create new opportunities for multi-therapy infusion pump manufacturers.
  • Growing importance of multi-therapy infusion pumps in clinical nutrition industry will open new windows for manufacturers.

Challenges for Companies/Manufacturers in the Multi-therapy Infusion Pumps Industry:

  • The increasing frequency of product recalls, lack of experienced specialists, and standard usage instructions are the primary market restraints.
  • The side effects of infusion pump systems, such as software difficulties, insufficient user interface design, faulty components, alarm failures, and shocks, can keep the market from growing.
  • The high expense of treatment due to the usage of high-tech modalities might also limit market expansion.

Opportunities in the Multi-therapy Infusion Pumps Industry:

  • Focus of infusion pump manufacturers on developing compact and lightweight devices that are easy to carry and operate is anticipated to create lucrative opportunities.
  • Increasing incidence of chronic diseases globally and rising number of surgical procedures are set to increase the demand for multi-therapy infusion pumps.
  • Growing focus on emerging markets with a need for specialty infusion systems could offer significant growth opportunities for players in the market.

Latest Trends in the Multi-therapy Infusion Pumps Market:

  • Efficient and advanced control features and customization are the targets of innovators in the field of multi-therapy infusion pumps to make it more-user friendly.
  • Focused approach of healthcare providers on reducing the risk of unnecessary harm caused by systemic negligence or error in the healthcare system is leading to innovations in infusion pumps technology.
  • Adoption of smart multi-therapy infusion pumps that can self-diagnose, self-clean, and optimize energy consumption has been growing across several regions globally.
Attribute Key Insights
Estimated Global Multi-Therapy Infusion Pumps Market Size (2023) USD 370.4 million
Projected Multi-Therapy Infusion Pumps Market Projected Value (2033) USD 699.4 million
Value-based CAGR (2023 to 2033) 6.6%

2018 to 2022 Multi-Therapy Infusion Pumps Sales Outlook Compared to Demand Forecast from 2023 to 2033

From 2018 to 2022, the global multi-therapy infusion pumps industry experienced a CAGR of 7.3%. Total market value at the end of 2022 reached around USD 347.9 million.

Looking ahead, the global multi-therapy infusion pumps industry is anticipated to rise at a CAGR of 6.6% from 2023 to 2033. During the forecast period, the market value is expected to reach USD 699.4 million.

Growth in the market is driven by rising prevalence of chronic disease along with the increasing geriatric population.

Infusion pump technology was brought into healthcare 45 years ago. Its main purpose was to monitor the rate and volume of intravenous drugs to improve safety when providing cardiovascular medication. The smart pump's principal role is to provide the correct dose.

The multi-therapy infusion pumps industry is expected to continue its growth trajectory from 2023 to 2033. Rising demand for ambulatory infusion pumps and growing volume of surgical procedures will boost the market.

Most multi-therapy infusion pumps have built-in safety mechanisms and alarms for operator alerts that will trigger in the event of a malfunction. Several illnesses, including immunological deficiencies, cancer, and congestive heart failure, cannot be managed with oral drugs. They must be treated with infusion therapy.

The need for infusion pumps is predicted to increase significantly as the prevalence of diseases such as diabetes, cancer, and heart disease is expected to rise due to rapid lifestyle changes. This in turn will create lucrative opportunities for multi-therapy infusion manufacturing companies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

What is Driving Demand for Multi-therapy Infusion Pumps in the United States?

Rising Prevalence of Chronic Diseases Driving Multi-therapy Infusion Pump Demand in the United States

Country United States
Market Size (USD million) by End of Forecast Period (2033) USD 198.0 million
CAGR % from 2023 to End of Forecast (2033) 6.1%

The United States multi-therapy infusion pumps market is expected to reach a valuation of USD 198.0 million by 2033, expanding at a CAGR of 6.1%. Demand for multi-therapy infusion pumps in the United States is expected to rise due to the growing prevalence of chronic diseases.

Six out of every ten Americans have a chronic health condition, such as stroke or cardiovascular disease, tumors, or diabetic mellitus. To effectively and continuously deliver medicine and fluids to disease, multi-therapy infusion pumps are used.

Availability of advanced products and strong presence of leading multi-therapy infusion companies are also influencing the United States market expansion.

How is the United Kingdom Multi-therapy Infusion Pumps Market Shaping?

High Adoption of Infusion Pumps in Analgesic Therapy Boosting the United Kingdom Market

Country United Kingdom
Market Size (USD million) by End of Forecast Period (2033) USD 45.2 million
CAGR % from 2023 to End of Forecast (2033) 7.9%

The multi-therapy infusion pumps industry in the United Kingdom is projected to top a valuation of USD 45.2 million by 2033. Overall sales of multiple-therapy infusion pumps in the country are likely to soar at 7.9% CAGR during the forecast period.

The United Kingdom market is projected to experience growth owing to the rising demand for analgesic infusion pumps in pain management.

As analgesic infusion pumps can provide focused pain management while minimizing side effects, their use in surgical procedures is growing. This in turn is providing impetus for the growth of the market for multi-therapy infusion pumps.

What is Boosting the Expansion of the Multi-therapy Infusion Pumps Industry in China?

Government Focus on Product Development to Boost China Multi-therapy Infusion Pumps Industry

Country China
Market Size (USD million) by End of Forecast Period (2033) USD 16.2 million
CAGR % from 2023 to the End of Forecast (2033) 6.3%

According to Future Market Insights (FMI), China multi-therapy infusion pumps industry is anticipated to reach a valuation of USD 16.2 million by 2033. Total demand for multi-therapy infusion pumps in the country is forecast to surge at 6.3% CAGR during the forecast period.

Growth in the market is expected to be driven by government’s favorable regulations for product developments. The Chinese government has created medical equipment regulatory frameworks and standards, including infusion pumps.

In China, the National Medical Products Administration (NMPA) is the regulatory body in charge of guaranteeing the safety and efficacy of medical devices. They enforce legislation, develop standards, and perform inspections to verify that quality and safety criteria are met.

China’s exploding population and surge in cases of various chronic diseases will also positively influence multi-therapy infusion pump demand during the next ten years.

What is the Growth Projection for Japan Market?

Increasing Adoption of Home Healthcare Services to Drive Japan Multi-therapy Infusion Pumps Market

Country Japan
Market Size (USD million) by End of Forecast Period (2033) USD 14.2 million
CAGR % from 2023 to the End of Forecast (2033) 7.1%

Japan multi-therapy infusion pumps industry is projected to cross a valuation of USD 14.2 million by 2033. It is likely to exhibit a CAGR of 7.1% from 2023 to 2033.

Rising adoption of home healthcare services is emerging as a key factor driving multi-therapy infusion pump demand in Japan.

Home healthcare services have been growing in Japan to support elderly and chronically ill patients. Infusion pumps play a vital role in enabling the administration of intravenous medications or fluids in a home setting, which increases the demand for these devices.

Why is South Korea Emerging as a Lucrative Market for Multi-therapy Infusion Pump Manufacturers?

Improved Healthcare Infrastructure Making Korea a Lucrative Market for Manufacturers

Country South Korea
Market Size (USD million) by End of Forecast Period (2033) USD 8.0 million
CAGR % from 2023 to the End of Forecast (2033) 6.8%

As per Future Market Insights, multi-therapy infusion pump demand in Korea is expected to rise at 6.8% CAGR during the assessment period. Total market valuation in Korea is anticipated to reach a valuation of USD 8.0 million.

South Korea has a well-developed healthcare system with advanced medical facilities. Hospitals and healthcare institutions require a significant number of infusion pumps to support patient care and treatment.

Further, infusion pump technology continues to evolve, offering improved features such as better accuracy, safety mechanisms, and programmable settings which is aiding the market growth in the country.

Category-wise Insights

Which Modality of Multi-therapy Infusion Pumps Remain Popular in the Market?

Demand to Remain High for Table Top Multi-Therapy Infusion Pumps

According to Future Market Insights (FMI), table top segment is expected to dominate the multi-therapy infusion pumps industry. This is due to rising popularity of table top multi-therapy infusion pumps on account of their various attractive features.

Tabletop multi-therapy infusion pumps are medical equipment that may administer various therapies at the same time or sequentially. They include innovative features that ensure correct and controlled administration of fluids and drugs.

The table top segment is anticipated to progress at a CAGR of 6.2% from 2023 to 2033. It will hold a prominent share of the global market by the end of 2033.

Demand for tabletop multi-therapy infusion pumps is likely to remain high in the market due to their smooth and continuous mode of operation and unparalleled ease of use. Hence, companies must expand their table top infusion pumps portfolios to maximize their profits.

Which Application Holds Maximum Potential for the Growth of Multi-therapy Infusion Pumps Industry?

Parenteral Nutrition to Create Lucrative Growth Prospects for the Market

Parenteral nutrition segment is expected to lead the multi-therapy infusion pumps industry. It is likely to thrive at a CAGR of 7.4% from 2023 to 2033, making it one of the lucrative application segments.

The target segment will capture a significant market share in 2023. This is due to the increasing need for personalized nutritional therapy and ability of infusion pumps to quickly deliver specialized food forms.

Rising need for individualized nutrition therapy is assisting in the expansion of the parenteral nutrition market sector. This in turn is creating high demand for multi-therapy pumps.

Multi-therapy infusion pumps provide precise control over infusion rates and volumes. This is critical in personalizing PN therapy to each patient's individual nutritional needs. Depending on the patient's needs, the pump can be configured to supply different components of the PN solution at varying rates.

Rising incidence of malnutrition especially among hospitalized patients will further boost growth of the target segment.

As per a report published in the National Library of Medicine (NLM), malnutrition has become a highly prevalent condition in the acute hospital setting. It affects around 40% of hospitalized patients. To prevent or treat malnutrition, healthcare workers use multi-therapy infusion pumps.

Which Segment on the Basis of End-use is Leading Demand for Multi-therapy Pumps?

Hospitals to Remain Leading End-users of Multi-Therapy Infusion Pumps

As per the latest analysis, hospitals will remain the leading end user of multi-therapy infusion pumps. This is due to the high demand for critical patient care in the hospitals.

The hospitals segment is anticipated to progress at 7.2% CAGR between 2023 and 2033. It will hold a dominant share of the global multi-therapy infusion pumps industry by the end of 2033.

In pediatric hospitals, multi-therapy infusion pumps are commonly used to provide drugs and fluids to children. Their configurable features and safety mechanisms are notably useful for ensuring proper dosing and reducing pharmaceutical mishaps.

Similarly, in intensive care units (ICUs) and other critical care settings, multi-therapy infusion pumps are very important. They aid in the administration of numerous drugs, including vasopressors, sedatives, and antiarrhythmics, to stabilize patients and manage critical circumstances. Due to mentioned factors, the adoption of multi-therapy infusion pumps in hospitals is high.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How do Key Players Stay Competitive in the Multi-Therapy Infusion Pumps Industry?

The multi-therapy infusion pumps industry is highly competitive, with numerous players vying for market share. In such a scenario, key multi-therapy infusion pump manufacturers must adopt effective strategies to stay ahead of the competition.

Key Strategies Adopted by the Players:

  • Product Innovation/Launches

Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.

  • Strategic Partnerships and Collaborations

Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.

  • Mergers and Acquisitions

Key players in the multi-therapy infusion pump industry often engage in mergers and acquisitions to strengthen their position, expand their product portfolio, and gain access to new markets.

Key Manufacturers of Multi-Therapy Infusion Pumps Include

  • MOOG Inc.
  • pfm Medical ag
  • BD
  • AVA Biomedical
  • ICU Medical
  • ANGEL Electronics
  • B. Braun

Key Developments in the Multi-Therapy Infusion Pumps Industry:

  • Eitan Medical released Avoset in April 2023 in European Countries. Avoset is an innovative interconnected infusion multi-therapy ambulatory infusion system.
  • In June 2020, Hirtz & Co. KG (HiCo) was acquired by pfm Medical Ag. The acquisition will enable pfm Medical, a multinational corporation, to diversify its medical device portfolio.
  • Recently, Smiths Medical (ICU Medical, Inc.) entered into an exclusive agreement with Ivenix, Inc. The collaboration makes the company first in the United States with a comprehensive suite of infusion management solutions.

Scope of the Report

Attribute Details
Market Size Value in 2023 USD 370.4 million
Market Forecast Value in 2033 USD 699.4 million
Anticipated Growth Rate (2023 to 2033) 6.6% CAGR
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis Volume (MT) and Value (USD Million)
Key Regions Covered Latin America; North America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, and others
Key Market Segments Covered Product Type, Nature, Form, Processing Type, Packaging Format, Sales Channel, and Region
Key Companies Profiled MOOG Inc.; pfm medical ag; BD; AVA Biomedical; ICU medical; ANGEL Electronics; B. Braun

Multi-Therapy Infusion Pumps Market Segmentation

By Modality:

  • Pole Mounted
  • Table Top

By Application:

  • Parenteral Nutrition
  • Analgesic Therapy
  • Chemotherapy
  • Antibiotic Therapy
  • Desferal Therapy
  • Chronotherapy

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Clinics
  • Homecare Setting

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

What is Driving the Multi-Therapy Infusion Pumps Market?

The demand for portable and user-friendly infusion pump systems is driving the market.

How is the Market Influenced by Regulatory Changes in Different Regions?

Product approval procedures, safety requirements, and market entrance obstacles.

What are the Current Trends in the Multi-Therapy Infusion Pumps Market?

Smart infusion systems and wireless connectivity for remote monitoring.

How Technology is Shaping the Multi-Therapy Infusion Pumps Market?

Technical improvements in the demand for precise drug delivery is surging the market expansion.

Which Region is Dominating the Multi-Therapy Infusion Pumps?

North America is dominating the multi-therapy infusion pumps market.

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Value-Added Insights
  • 5. Market Background
  • 6. Global Market Volume (in Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Demand (in Value or Size in US$ million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
  • 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
    • 9.1. Pole Mounted
    • 9.2. Table Top
  • 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    • 10.1. Parenteral Nutrition
    • 10.2. Analgesic Therapy
    • 10.3. Chemotherapy
    • 10.4. Antibiotic Therapy
    • 10.5. Desferal Therapy
    • 10.6. Chronotherapy
  • 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    • 11.1. Hospitals
    • 11.2. Specialty Clinics
    • 11.3. Ambulatory Clinics
    • 11.4. Homecare Setting
  • 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
    • 12.1. North America
    • 12.2. Latin America
    • 12.3. Europe
    • 12.4. South Asia
    • 12.5. East Asia
    • 12.6. Oceania
    • 12.7. Middle East and Africa
  • 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 17. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 20. Market Structure Analysis
  • 21. Competition Analysis
    • 21.1. MOOG Inc.
    • 21.2. PFM medical ag
    • 21.3. BD
    • 21.4. AVA Biomedical
    • 21.5. ICU Medical
    • 21.6. ANGEL Electronics
    • 21.7. B. Braun
  • 22. Assumptions and Acronyms Used
  • 23. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Multi-therapy Infusion Pumps Market

Schedule a Call